You have been selected to receive this newsletter based on your interest in learning more about host cell protein detection and analysis. It contains some of our most popular HCP-related content. Read on and let us help you advance your research.
Sponsored by
Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics as well as in innovative viral clearance solutions.
A robust and broadly reactive host cell protein (HCP) ELISA is a critical component of monitoring purification process consistency as well as final drug ...
Download »
"Host cell proteins (HCPs) co-purify with biological drug substances (DS) and pose potential risks for both patients and drug manufacturers. Regulatory ...
Download »
Cygnus Technologies has performed an antibody coverage bridging study between the F550 and F550-1 versions of our 3rd generation CHO ELISA kits by Antibody ...
Download »
Antibody Affinity Extraction, a method superior to 2D WB for determination of coverage to anti-HCP antibodies allowing for detection of individual downstream HCPs More »
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings
or Unsubscribe here
